SBH
INSM icon

Segall Bryant & Hamill’s Insmed INSM Stock Holding History

Segall Bryant & Hamill’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-119,136
Closed -$12M – 605
2025
Q2 		$12M Sell
119,136
-51,723
-30% -$3.95M 0.17% 199
2025
Q1 		$13M Buy
170,859
+31,814
+23% +$2.43M 0.2% 155
2024
Q4 		$9.6M Sell
139,045
-1,870
-1% -$135K 0.13% 229
2024
Q3 		$10.3M Sell
140,915
-5,761
-4% -$425K 0.14% 228
2024
Q2 		$9.83M Buy
+146,676
New +$5.69M 0.17% 194

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Segall Bryant & Hamill's INSM Position: Q3 2025 in Review

Segall Bryant & Hamill sold out of Insmed (INSM) in Q3 2025, closing a stake of 119,136 shares — an estimated $12M sold.

Segall Bryant & Hamill first reported a position in INSM in Q2 2024 and held it in 5 quarters. The position peaked at $13M in Q1 2025. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

  • Segall Bryant & Hamill reported no remaining Insmed position as of Q3 2025 after selling out during the quarter.
  • Segall Bryant & Hamill sold 119,136 Insmed shares in Q3 2025, an estimated $12M.
  • Segall Bryant & Hamill first reported a position in Insmed in Q2 2024 and held it in 5 quarters.
  • Segall Bryant & Hamill's Insmed position peaked at $13M in Q1 2025.
  • 566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on Segall Bryant & Hamill's 13F filing for Q3 2025, filed 12 Nov 2025.